Home › Prostate Cancer › Texas › Austin
Prostate Cancer clinical trials in Austin, TX
14 studies for Prostate Cancer are looking for participants at sites in and around Austin (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
WATER IV PCa (AS Sub-study)
Recruiting
- Midtown Urology, Austin
- Urology Austin, Austin
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
RecruitingPhase 4
- Urology Austin, Austin
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
RecruitingPhase 1/2
- NEXT Oncology, Austin
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RecruitingPhase 1/2
- Research Site 135, Austin
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RecruitingPhase 3
- Texas Oncology - Central/South Texas ( Site 8003), Austin
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
RecruitingPhase 3
- Research Site, Austin
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
RecruitingPhase 3
- Urology Austin, Lakeway · 16 mi away
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
RecruitingPhase 3
- Research Site, Austin
- Research Site, Austin
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- New Experimental Therapeutics - NEXT Oncology, Austin
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
Recruiting
- Urology Austin, Austin
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
RecruitingPhase 3
- Urology Austin, PLLC - Research Department, Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
- NEXT Oncology Austin, Austin
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
RecruitingPhase 1
- NEXT Oncology, Austin, TX 78758
Sample Collection for Ongoing Research and Product Evaluation Study
RecruitingObservational study
- Natera, Inc., Austin
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY101 studies
- Houston, TX73 studies
- Los Angeles, CA64 studies
- Boston, MA56 studies
- Seattle, WA45 studies
- St. Louis, MO45 studies
- Chicago, IL45 studies
- Baltimore, MD45 studies
- San Francisco, CA44 studies
- Philadelphia, PA41 studies
- Nashville, TN40 studies
- Washington, DC39 studies
Other studies in Austin
- Non-Small Cell Lung Cancer29 studies
- Cancer (all types)22 studies
- Obesity22 studies
- Overweight19 studies
- Metastatic Cancer18 studies
- Colorectal Cancer17 studies
- Ovarian Cancer17 studies
- Heart Failure17 studies
- Endometrial Cancer15 studies
- Breast Cancer15 studies
- Type 2 Diabetes14 studies
- Steatotic Liver Disease13 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.